Literature DB >> 9620939

Relapsing nodular lesions in the course of adult pulmonary Langerhans cell histiocytosis.

A Tazi1, L Montcelly, A Bergeron, D Valeyre, J P Battesti, A J Hance.   

Abstract

In most patients with pulmonary Langerhans cell histiocytosis (LCH), clinical and radiological abnormalities initially either stabilize or regress, often without treatment. Little information is available, however, concerning the subsequent evolution of disease in patients who initially follow a benign course. We describe four patients with biopsy-confirmed pulmonary LCH whose initial course was characterized by regression of parenchymal nodular lesions, but who subsequently developed one or more episodes of active disease 7 mo to 7.5 yr after their initial presentation. In each case, the subsequent episodes of active disease were characterized by the reappearance or marked increase in nodular radiographic abnormalities, whose presence was confirmed by high-resolution computed tomography (HRCT). Thus, initial regression of nodular lesions in pulmonary LCH does not preclude the reappearance of one or more episodes of active disease, and may have important consequences on the long-term prognosis of these patients.

Entities:  

Mesh:

Year:  1998        PMID: 9620939     DOI: 10.1164/ajrccm.157.6.9709026

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  12 in total

Review 1.  Adult pulmonary Langerhans' cell histiocytosis.

Authors:  A Tazi; P Soler; A J Hance
Journal:  Thorax       Date:  2000-05       Impact factor: 9.139

Review 2.  Rare lung diseases III: pulmonary Langerhans' cell histiocytosis.

Authors:  Stephen C Juvet; David Hwang; Gregory P Downey
Journal:  Can Respir J       Date:  2010 May-Jun       Impact factor: 2.409

3.  A solitary pulmonary ground-glass nodule in adult systemic langerhans' cell histiocytosis.

Authors:  Ying Zhou; Yunyuan Li; Li Fan; Shiyuan Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

4.  Complete disappearance of lung abnormalities on high-resolution computed tomography: a case of histiocytosis X.

Authors:  Sergio Negrin-Dastis; Dominique Butenda; Jacques Dorzee; Jacques Fastrez; Jean-Paul d'Odémont
Journal:  Can Respir J       Date:  2007 May-Jun       Impact factor: 2.409

Review 5.  Imaging of macrophage-related lung diseases.

Authors:  Katharina Marten; David M Hansell
Journal:  Eur Radiol       Date:  2005-01-05       Impact factor: 5.315

Review 6.  Histiocytic disorders.

Authors:  Kenneth L McClain; Camille Bigenwald; Matthew Collin; Julien Haroche; Rebecca A Marsh; Miriam Merad; Jennifer Picarsic; Karina B Ribeiro; Carl E Allen
Journal:  Nat Rev Dis Primers       Date:  2021-10-07       Impact factor: 65.038

Review 7.  Pulmonary langerhans cell histiocytosis.

Authors:  Harpreet S Suri; Eunhee S Yi; Gregorz S Nowakowski; Robert Vassallo
Journal:  Orphanet J Rare Dis       Date:  2012-03-19       Impact factor: 4.123

8.  The natural history of adult pulmonary Langerhans cell histiocytosis: a prospective multicentre study.

Authors:  Abdellatif Tazi; Constance de Margerie; Jean Marc Naccache; Stéphanie Fry; Stéphane Dominique; Stéphane Jouneau; Gwenaël Lorillon; Emmanuelle Bugnet; Raphael Chiron; Benoit Wallaert; Dominique Valeyre; Sylvie Chevret
Journal:  Orphanet J Rare Dis       Date:  2015-03-14       Impact factor: 4.123

9.  Effectiveness of cladribine therapy in patients with pulmonary Langerhans cell histiocytosis.

Authors:  Vincent Grobost; Chahera Khouatra; Romain Lazor; Jean-François Cordier; Vincent Cottin
Journal:  Orphanet J Rare Dis       Date:  2014-11-30       Impact factor: 4.123

10.  Pulmonary Langerhans cell histiocytosis: the many faces of presentation at initial CT scan.

Authors:  M C Castoldi; A Verrioli; E De Juli; A Vanzulli
Journal:  Insights Imaging       Date:  2014-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.